Overview

Effectiveness of Ursodeoxycholic Acid Use in the Prevention of Gallstone Formation After Sleeve Gastrectomy

Status:
Unknown status
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
This is a randomized double-blind placebo-controlled trial with a total of 100 patients who are free of gallstones at baseline. The study involves taking an oral drug (Ursodeoxycholic Acid 250mg) or a placebo twice daily for a period of six months and undergoing a total of three abdominal ultrasounds (at 6 months, at 12 months, and at 18 months) to check for gallstones.
Phase:
Phase 3
Details
Lead Sponsor:
American University of Beirut Medical Center
Collaborator:
Makassed General Hospital
Treatments:
Ursodeoxycholic Acid